UPXIN

This brand name is authorized in Nigeria.

Active ingredients

The drug UPXIN contains a combination of these active pharmaceutical ingredients (APIs):

`1`	Artemisinin UNII `6A9O50735X` - ARTENIMOL
	Artemisinin is used in the treatment of malaria due to species Plasmodium.
	Read more about Artemisinin
`2`	UNII `854D7K8LXB` - PIPERAQUINE PHOSPHATE
	Read more about

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-3672	Capsule	Upxin CAP 40 mg; 320 mg 3 x 3's	Softgel Capsule	28/10/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
P01BF07		P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01B Antimalarials → P01BF Artemisinin and derivatives, combinations
Discover more medicines within P01BF07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-3672

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.